Mark Sorbero

Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002–11

Andrew W. Dick, Rosalie Liccardo Pacula, Adam J. Gordon et al. · Health Affairs · 2015 · 156 citations · Full text

A Population-Based Examination of Trends and Disparities in Medication Treatment for Opioid use Disorders among Medicaid Enrollees

Bradley D. Stein, Andrew W. Dick, Mark Sorbero et al. · Substance Abuse · 2018 · 117 citations

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Bradley D. Stein, Mark Sorbero, Andrew W. Dick et al. · JAMA · 2016 · 114 citations · Full text

Substance Use Disorders, Opioid Epidemic, Substance Use +12

Supply of buprenorphine waivered physicians: The influence of state policies

Bradley D. Stein, Adam J. Gordon, Andrew W. Dick et al. · Journal of Substance Abuse Treatment · 2014 · 108 citations · Full text

Opioid Epidemic, Public Policy, Primary Care +6

Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties

Bradley D. Stein, Rosalie Liccardo Pacula, Adam J. Gordon et al. · Milbank Quarterly · 2015 · 98 citations · Full text